| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2040429 | F | Cytotoxicity against human HCC1806 cells after 48 hrs by MTT assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 2. | ALA985245 | F | Cytotoxicity against human HCC1806 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 3. | ALA2363260 | F | SANGER: Inhibition of human HCC1806 cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
| 4. | ALA5254995 | F | Antiproliferative activity against human HCC1806 cells assessed as inhibition of cell growth at 20 uM by SRB assay relative to control | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
| 5. | ALA5254997 | F | Antiproliferative activity against human HCC1806 cells assessed as inhibition of cell growth by SRB assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 6. | ALA5254998 | F | Induction of cell cycle arrest in human HCC1806 cells assessed as accumulation at S phase at 10 uM incubated for 24 hrs by flow cytometric analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 7. | ALA5254999 | F | Induction of cell cycle arrest in human HCC1806 cells assessed as decrease in G2/M phase cells at 10 uM incubated for 24 hrs by flow cytometric analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 8. | ALA5255003 | F | Antitumor activity against human HCC1806 cells assessed as reduction in p53 protein level at 10 uM incubated for 24 hrs by Western blot analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 9. | ALA5255004 | F | Antitumor activity against human HCC1806 cells assessed as induction of phosphorylated p38 protein accumulation at 10 uM incubated for 24 hrs by Western blot analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 10. | ALA5255005 | F | Antitumor activity against human HCC1806 cells assessed as induction of p21 protein accumulation at 10 uM incubated for 24 hrs by Western blot analysis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 11. | ALA3271210 | F | Antiproliferative activity against ER, PR, HER2-deficient human HCC1806 cells as growth inhibition after 24 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 12. | ALA3271211 | F | Antiproliferative activity against ER, PR, HER2-deficient human HCC1806 cells as growth inhibition after 48 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 13. | ALA3271212 | F | Antiproliferative activity against ER, PR, HER2-deficient human HCC1806 cells as growth inhibition after 72 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 14. | ALA3271579 | F | Antiproliferative activity against ER, PR, HER2-deficient human HCC1806 cells as growth inhibition after 96 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 15. | ALA3271589 | F | Cytotoxicity against ER, PR, HER2-deficient human HCC1806 cells as reduction of survival factor at IC50 incubated for 48 hrs measured after 12 days by crystal violet staining-based clonogenic assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 16. | ALA3271591 | F | Cytotoxicity against ER, PR, HER2-deficient human HCC1806 cells as reduction of total protein content at IC50 incubated for 48 hrs by SRB assay relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 17. | ALA3271593 | F | Induction of apoptosis in triple negative ER, PR, HER2-deficient human HCC1806 cells assessed as increase of late apoptotic/nectrotic cells at IC50 after 48 hrs by Annexin V/propidium iodide staining-based flow cytometry relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA3271594 | F | Induction of apoptosis in triple negative ER, PR, HER2-deficient human HCC1806 cells assessed as decrease of viable cells at IC50 after 48 hrs by Annexin V/propidium iodide staining-based flow cytometry relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 19. | ALA3271598 | F | Induction of apoptosis in triple negative ER, PR, HER2-deficient human HCC1806 cells assessed as increase of necrotic cells at IC50 after 48 hrs by Annexin V/propidium iodide staining-based flow cytometry relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 20. | ALA3271601 | F | Induction of apoptosis in ER, PR, HER2-deficient human HCC1806 cells as increase in Bax/Bcl2 expression ratio at IC50 after 48 hrs by Western blotting analysis relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!